1. Home
  2. VIOT vs FLNA Comparison

VIOT vs FLNA Comparison

Compare VIOT & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viomi Technology Co. Ltd

VIOT

Viomi Technology Co. Ltd

HOLD

Current Price

$0.80

Market Cap

53.9M

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$1.22

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIOT
FLNA
Founded
2014
1998
Country
China
United States
Employees
N/A
20
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.9M
61.8M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
VIOT
FLNA
Price
$0.80
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
206.1K
320.5K
Earning Date
03-25-2026
05-13-2026
Dividend Yield
13.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
$3.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$1.15
52 Week High
$4.33
$2.03

Technical Indicators

Market Signals
Indicator
VIOT
FLNA
Relative Strength Index (RSI) 38.28 44.72
Support Level N/A $1.16
Resistance Level $1.05 $1.80
Average True Range (ATR) 0.06 0.07
MACD -0.00 0.01
Stochastic Oscillator 32.46 44.44

Price Performance

Historical Comparison
VIOT
FLNA

About VIOT Viomi Technology Co. Ltd

Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: